◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Vaxil Bio Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 184,000 145,000 239,000 428,000
General And Administrative Expense 184,000 145,000 239,000 428,000
Research And Development 12,000 114,000 343,000 539,000
Depreciation And Amortization In Income Statement -- 0.00 2,000 19,000
Operating Expense 196,000 259,000 584,000 986,000
Operating Income -196,000 -259,000 -584,000 -986,000
EBIT -196,000 -259,000 -584,000 -986,000
Interest Expense -- -- -- 0.00
Interest Expense Non Operating -- -- -- 0.00
Interest Income 18,000 0.00 -- --
Interest Income Non Operating 18,000 0.00 -- --
Net Interest Income 18,000 0.00 -- 0.00
Other Income Expense -- 5,000 -- --
Special Income Charges 0.00 5,000 0.00 --
Pretax Income -178,000 -254,000 -584,000 -986,000
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -178,000 -254,000 -584,000 -986,000
Net Income From Continuing Operation Net Minority Interest -178,000 -254,000 -584,000 -986,000
Net Income Including Noncontrolling Interests -178,000 -254,000 -584,000 -986,000
Net Income Common Stockholders -178,000 -254,000 -584,000 -986,000
Net Income -178,000 -254,000 -584,000 -986,000
EBITDA -196,000 -259,000 -582,000 -961,000
Normalized EBITDA -196,000 -264,000 -582,000 -961,000
Reconciled Depreciation -- 0.00 2,000 25,000
Basic EPS -0.05 -0.10 -0.50 -0.50
Diluted EPS -0.05 -0.10 -0.50 -0.50
Basic Average Shares 2.7M 2.7M 2.7M 2.7M
Diluted Average Shares 2.7M 2.7M 2.7M 2.7M
Total Unusual Items 0.00 5,000 0.00 --
Total Unusual Items Excluding Goodwill 0.00 5,000 0.00 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -178,000 -259,000 -584,000 -986,000
Depreciation Amortization Depletion Income Statement -- 0.00 2,000 19,000
Depreciation Income Statement -- 0.00 2,000 19,000
Diluted NI Availto Com Stockholders -178,000 -254,000 -584,000 -986,000
Gain On Sale Of Ppe 0.00 5,000 0.00 --
Insurance And Claims 21,000 20,000 17,000 --
Net Income Continuous Operations -178,000 -254,000 -584,000 -986,000
Net Non Operating Interest Income Expense 18,000 0.00 -- 0.00
Other Gand A 142,000 85,000 192,000 329,000
Rent And Landing Fees 16,000 20,000 13,000 29,000
Rent Expense Supplemental 16,000 20,000 13,000 29,000
Salaries And Wages 5,000 20,000 17,000 70,000
Total Expenses 196,000 259,000 584,000 986,000
Total Operating Income As Reported -196,000 -254,000 -584,000 -986,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 448,000 938,000 1.5M 2.2M
Cash Cash Equivalents And Short Term Investments 448,000 938,000 1.5M 2.2M
Cash Financial -- 938,000 1.5M 2.2M
Receivables 273,000 19,000 20,000 35,000
Prepaid Assets 12,000 19,000 11,000 7,000
Current Assets 733,000 976,000 1.5M 2.3M
Gross PPE -- -- 213,000 213,000
Accumulated Depreciation -- -- -213,000 -211,000
Net PPE -- -- 0.00 2,000
Total Non Current Assets 0.00 0.00 0.00 2,000
Total Assets 733,000 976,000 1.5M 2.3M
Payables And Accrued Expenses 17,000 85,000 405,000 585,000
Current Liabilities 17,000 85,000 405,000 585,000
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 17,000 85,000 405,000 585,000
Common Stock 16.1M 16.1M 16.1M 16.1M
Capital Stock 16.1M 16.1M 16.1M 16.1M
Retained Earnings -19.5M -19.4M -19.1M -18.5M
Gains Losses Not Affecting Retained Earnings 4.2M 4.2M 3.8M 3.8M
Other Equity Adjustments 4.2M 4.2M 3.8M 3.8M
Common Stock Equity 716,000 891,000 1.1M 1.7M
Stockholders Equity 716,000 891,000 1.1M 1.7M
Total Equity Gross Minority Interest 716,000 891,000 1.1M 1.7M
Total Capitalization 716,000 891,000 1.1M 1.7M
Net Tangible Assets 716,000 891,000 1.1M 1.7M
Tangible Book Value 716,000 891,000 1.1M 1.7M
Working Capital 716,000 891,000 1.1M 1.7M
Invested Capital 716,000 891,000 1.1M 1.7M
Total Debt -- -- -- 0.00
Share Issued 2.7M 2.7M 2.7M 2.7M
Ordinary Shares Number 2.7M 2.7M 2.7M 2.7M
Capital Lease Obligations -- -- -- 0.00
Current Capital Lease Obligation -- -- -- 0.00
Leases -- -- -- 122,000
Machinery Furniture Equipment -- -- 17,000 17,000
Notes Receivable 266,000 0.00 -- --
Other Equity Interest -- -- 324,000 358,000
Other Properties -- -- 196,000 196,000
Taxes Receivable 7,000 19,000 20,000 35,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -240,000 -561,000 -734,000 -1.1M
Cash Flow From Continuing Operating Activities -240,000 -561,000 -734,000 -1.1M
Depreciation And Amortization -- 0.00 2,000 25,000
Depreciation Amortization Depletion -- 0.00 2,000 25,000
Stock Based Compensation 5,000 20,000 17,000 70,000
Change In Working Capital -49,000 -327,000 -169,000 -193,000
Changes In Account Receivables 19,000 -7,000 11,000 82,000
Change In Receivables 19,000 -7,000 11,000 82,000
Change In Payables And Accrued Expense -68,000 -320,000 -180,000 -275,000
Change In Payable -- -- -- -275,000
Other Non Cash Items -18,000 -- -- --
Investing Cash Flow -250,000 0.00 -- --
Cash Flow From Continuing Investing Activities -250,000 0.00 -- --
Repayment Of Debt -- -- 0.00 -9,000
Net Issuance Payments Of Debt -- -- 0.00 -9,000
Issuance Of Capital Stock -- -- -- 0.00
Net Common Stock Issuance -- -- -- 0.00
Financing Cash Flow -- -- 0.00 1.8M
Cash Flow From Continuing Financing Activities -- -- 0.00 1.8M
Effect Of Exchange Rate Changes 0.00 -11,000 3,000 7,000
Changes In Cash -490,000 -561,000 -734,000 724,000
Beginning Cash Position 938,000 1.5M 2.2M 1.5M
End Cash Position 448,000 938,000 1.5M 2.2M
Free Cash Flow -240,000 -561,000 -734,000 -1.1M
Change In Account Payable -- -- -- -275,000
Common Stock Issuance -- -- -- 0.00
Depreciation -- 0.00 2,000 25,000
Long Term Debt Payments -- -- 0.00 -9,000
Net Income From Continuing Operations -178,000 -254,000 -584,000 -986,000
Net Long Term Debt Issuance -- -- 0.00 -9,000
Net Other Investing Changes -250,000 -- -- --
Proceeds From Stock Option Exercised -- -- 0.00 1.8M
NEWS
Loading news...
TRENDING
Loading...